Population health technology company Color announced it had laid off workers as it pivots focus away from COVID-19 testing.
Share: email Subscribe
Weekly Top Stories Tue, 07 Mar 2023
We have 27 articles this week # Walgreens expands in primary care with Starling Physicians’ acquisition #Burcon NutraScience to acquire Merit business. #Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging #Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities. #Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc. #JATT Acquisition Corp’s Proposed Business Combination with Zura Bio Limited Declared Effective by US SEC #Sesen Bio Stockholders Approve Merger with Carisma Therapeutics #Fertility company Kindbody scores $100M. The funds will be used to open new clinics in the U.S. #Lilly Bets $630M on Pain Target Novartis Failed
Editor's Choice
1. 
 Color Announces Layoffs as It Rolls Back Covid-19 Testing
2. 
 Thai Researchers Develop AI for Assessing Stroke Risk and More Briefs
3. 
 FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’
4. 
 Australia’s TGA clears TALi’s new attention training device and more briefs
5. 
 Resverlogix Announces New Research Highlighting Apabetalone’s Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19
Top 10 M&A Transactions
6. 
 Walgreens Expands in Primary Care with Starling Physicians’ Acquisition
7. 
 Burcon NutraScience to Acquire Merit Business
8. 
 Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packagin
9. 
 Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities
10. 
 Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
11. 
 JATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SEC
12. 
 Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
13. 
 Ipsen Completes Acquisition of Albireo, Expanding the Scope of Its Rare Disease Portfolio
14. 
 Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focused on Clinical Oncology
15. 
 Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, Llc
Top 3 Venture Funding
16. 
 Fertility Company Kindbody Scores $100M. The Funds Will be Used to Open New Clinics in the U.S.
17. 
 Lilly Bets $630M on Pain Target Novartis Failed
18. 
 AI Medical Coding Company Codametrix Raises $55M and More Digital Health Fundings
Top 2 Partnerships Announcements
19. 
 Radiopharm Theranostics Partners with Next Generation Preclinical Platform for Therapeutic Radiopharmaceuticals
20. 
 Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us